Effect of perioperative blood transfusions on long term graft outcomes in renal transplant patients

Clinical Nephrology

Volumn 77, Issue 6, 2012, Pages 432-437

  O'Brien, Frank J ^a   Lineen, James ^a   Kennedy, Claire M ^a   Phelan, Paul J ^a   O'Kelly, Patrick ^a   Denton, Mark D ^a   Magee, Colm ^a   Conlon, Peter J ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Blood transfusion; Graft survival; Renal transplantation

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; TACROLIMUS; BIOLOGICAL MARKER; HEMOGLOBIN;

ADULT; ARTICLE; BLOOD TRANSFUSION; COHORT ANALYSIS; CONTROLLED STUDY; DELAYED GRAFT FUNCTION; DRUG DOSE REDUCTION; FEMALE; GRAFT SURVIVAL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INFORMATION PROCESSING; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDY; ANEMIA; BLOOD; IRELAND; KAPLAN MEIER METHOD; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; TIME; TREATMENT OUTCOME;

ADULT; ANEMIA; BIOLOGICAL MARKERS; BLOOD TRANSFUSION; DELAYED GRAFT FUNCTION; FEMALE; GRAFT SURVIVAL; HEMOGLOBINS; HUMANS; IRELAND; KAPLAN-MEIER ESTIMATE; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIOPERATIVE CARE; PROPORTIONAL HAZARDS MODELS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84864540809     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN107436     Document Type: Article

References (19)

1. Scornik JC, Brunson ME, Howard RJ, Pfaff WW. Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation. Transplantation. 1992; 54: 389-394.
2. Leichtman AB, Cohen D, Keith D, O'Connor K, Goldstein M, McBride V, Gould CJ, Christensen LL, Ashby VB. Kidney and pancreas transplantation in the United States, 1997-2006; the HRSA Breakthrough Collaboratives and the 58 DSA Challenge. Am J Transplant 2008; 8: 946-957.
3. OPTN/SRTR. Annual Report. Transplant Data 1997-2006. www.ustransplant.org.
4. Denton MD, Magee CC, Sayegh MH. Immunosuppressive strategies in transplantation. Lancet. 1999; 353: 1083-1091.
5. Schiff J, Cole E, Cantarovich M. Therapeutic monitoring of calcineurin inhibitors for the nephrologist. Clin J Am Soc Nephrol. 2007; 2: 374-384.
6. Gaston RS. Maintenance immunosuppression in the renal transplant recipient: an overview. Am J Kidney Dis. 2001; 39 (Suppl): 25-35.
7. Fabrizili V, Winkelmayer WC, Klaus R, Kletzmayr J, Säemann MD, Steininger R, Kramar R, Hörl WH, Kovarik J. Patient and graft survival in older kidney transplant recipients: does age matter? J Am Soc Nephrol. 2004; 15: 1052-1060.
8. Terasaki PI, Ozawa M. Predicting kidney graft failure by HLA antibodies: a prospective trial. Am J Transplant. 2004; 4: 438-443.
9. Cecka JM et al. Sensitization in clinical transplants. UCLA Tissue typing laboratory, Los Angeles 1989.
10. Quiroga I, McShane P, Koo DD, Gray D, Friend PJ, Fuggle S, Darby C. Major effects of delayed graft function and cold ischaemia time on renal allograft survival. Nephrol Dial Transplant. 2006; 21: 1689-1696.
11. Madziarska K, Weyde W, Gosek K, Kopec W, Penar J, Klak R, Zukowska-Szczechowska E, Krajewska M, Kusztal M, Golebiowski T, Radziszewska D, Klinger M. Serum levels of proANP and albumin are independent predictors of mortality in high risk patients (elderly and diabetic) treated by haemodialysis and continuous peritoneal dialysis in 4 year prospective observation. Nephrol Dial Transplant. 2010; 25: 3800-3801.
12. Scornik JC, Schold JD, Bucci M, Meier-Kriesche HU. Effects of blood transfusions given after renal transplantation. Transplantation. 2009; 87: 1381-1386.
13. Opelz G, Vanrenterghem Y, Kirste G, Gray DW, Horsburgh T, Lachance JG, Largiader F, Lange H, Vujaklija-Stipanovic K, Alvarez-Grande J, Schott W, Hoyer J, Schnuelle P, Descoeudres C, Ruder H, Wujciak T, Schwarz V. Prospective evaluation of pre transplant blood transfusions in cadaver kidney recipients. Transplantation. 1997; 63: 964-967.
14. Cicciarelli J. UNOS Registry data: effect of transfusions. Clin Transpl. 1990; 407-416.
15. Aalten J, Bemelman FJ, van den Berg-Loonen EM, Claas FH, Christiaans MH, de Fijter JW, Hepkema BG, Hené RJ, van der Heide JJ, van Hooff JP, Lardy NM, Lems SP, Otten HG, Weimar W, Allebes WA, Hoitsma AJ. Pre kidney transplant blood transfusions do not improve transplantation outcome: a Dutch national study. Nephrol Dial Transplant. 2009; 24: 2559-2566.
16. Alexander JW, Light JA, Donaldson LA, Delmonico FL, Diethelm AG, Wilkinson A, Rosenthal JT, Thistlethwaite JR, Hunsicker LG, Matas AJ, First MR, Reinsmoen NL, Rose SM. Evaluation of pre and post transplant donor specific transfusion/cyclosporine A in non HLA identical living donor kidney transplant recipients. Transplantation. 1999; 68: 1117-1124.
17. Molnar MZ, Czira M, Ambrus C, Szeifert L, Szentkiralyi A, Beko G, Rosivall L, Remport A, Novak M, Mucsi I. Anemia is associated with mortality in kidney transplanted patients- a prospective cohort study. Am J Transplant. 2007; 7: 818-824.
18. Chhabra D, Grafals M, Skaro AI, Parker M, Gallon L. Impact of anemia after renal transplantation on patient and graft survival and on rate of acute rejection. Clin J Am Soc Nephrol. 2008; 3: 1168-1174.
19. Winkelmayer WC, Chandraker A, Alan Brookhart M, Kramar R, Sunder-Plassmann G. A prospective study of anemia and long term outcomes in kidney transplant recipients. Nephron Dial Transplant. 2006; 21: 3559-3566.